(19)
(11) EP 4 536 639 A1

(12)

(43) Date of publication:
16.04.2025 Bulletin 2025/16

(21) Application number: 23820421.8

(22) Date of filing: 07.06.2023
(51) International Patent Classification (IPC): 
C07D 215/22(2006.01)
A61K 31/47(2006.01)
A61P 33/00(2006.01)
C07D 403/04(2006.01)
A61K 31/4704(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 33/00; C07D 215/22; C07D 403/10; C07D 409/10; C07D 401/10
(86) International application number:
PCT/US2023/024746
(87) International publication number:
WO 2023/239811 (14.12.2023 Gazette 2023/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 07.06.2022 US 202263349930 P

(71) Applicants:
  • Oregon Health & Science University
    Portland, OR 97239 (US)
  • The United States Government As Represented By The Dept Of Veterans Affairs
    Washington, DC 20420 (US)

(72) Inventors:
  • RISCOE, Michael, K.
    Portland, OR 97239 (US)
  • NILSEN, Aaron
    Portland, OR 97239 (US)
  • DOGGETT, J. Stone
    Portland, OR 97239 (US)
  • ALDAY, Holland
    Portland, OR 97239 (US)
  • LIEBMAN, Katherine
    Portland, OR 97239 (US)
  • POU, Sovitj
    Portland, OR 97239 (US)
  • DODEAN, Rozalia
    Portland, OR 97239 (US)
  • WINTER, Rolf W.
    Portland, OR 97239 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) SUBSTITUTED BIARYL ENDOCHIN-LIKE QUINOLONES WITH ENHANCED ANTIPARASITIC ACTIVITY